Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial (original) (raw)

Drug-resistant tuberculosis: A disease of target populations in Houston, Texas

Larry D Teeter

Journal of Infection, 2006

View PDFchevron_right

Cross border, highly individualised treatment of a patient with challenging extensively drug-resistant tuberculosis

Henderik W . Frijlink

The European respiratory journal, 2018

View PDFchevron_right

Movement of Tuberculosis Patients and the Failure to Complete Antituberculosis Treatment

Janet Mohle-Boetani

American Journal of Respiratory and Critical Care Medicine, 1998

View PDFchevron_right

Morbidity rate of drug-susceptible tuberculosis and its medico-economic impact

Madiha Mushtaque

African Journal of Pharmacy and Pharmacology, 2020

View PDFchevron_right

The Medical Research Council and treatments for tuberculosis before streptomycin

Linda Bryder

Journal of the Royal Society of Medicine, 2014

View PDFchevron_right

Does tuberculosis screening improve individual outcomes? A systematic review

L. Mwenge

EClinicalMedicine, 2021

View PDFchevron_right

Factors associated with mortality in patients with tuberculosis

jose CASTILLO PAREDES

BMC Infectious Diseases, 2010

View PDFchevron_right

Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study

Timothy McHugh

BMJ Open, 2021

View PDFchevron_right

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Jai Mullerpattan

International Journal of Infectious Diseases, 2019

View PDFchevron_right

Tuberculosis; Relapse in Interrupted Antituberculous Therapy

Muhammad Abdur Rehman khadam, Awais Iqbal

THE PROFESSIONAL MEDICAL JOURNAL, 2017

View PDFchevron_right

Tuberculosis elimination: theory and practice in Europe

G. Migliori

European Respiratory Journal, 2014

View PDFchevron_right

Global Epidemiology of Tuberculosis

Mario Raviglione

Clinics in Chest Medicine, 2005

View PDFchevron_right

The return of tuberculosis

Richard Wenzel

Diagnostic Microbiology and Infectious Disease, 1999

View PDFchevron_right

Defining the Mandate of Tuberculosis Research in a Postgenomic Era

Seyed Hasnain

Medical Principles and Practice, 2004

View PDFchevron_right

Tuberculosis and noncommunicable diseases: neglected links and missed opportunities

Mario Raviglione

European Respiratory Journal, 2010

View PDFchevron_right

Clinical Immunology and Multiplex Biomarkers of Human Tuberculosis

Tom h.m. Ottenhoff

Cold Spring Harbor Perspectives in Medicine, 2014

View PDFchevron_right

Latent Tuberculosis: Advances in Diagnosis and Treatment

Georgia Vrioni

Pulmonary Infection, 2012

View PDFchevron_right

Tuberculosis in 2023: Assessing the Current Landscape and Progress towards Elimination Goals

ABHISHEK DHAWAN

International journal of science and research, 2024

View PDFchevron_right

Tuberculosis in Patients Receiving Antiretroviral Treatment: Incidence, Risk Factors, and Prevention Strategies

Ian Sanne

JAIDS Journal of Acquired Immune Deficiency Syndromes, 2011

View PDFchevron_right

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Sofia Alexandru

The Lancet, 2019

View PDFchevron_right

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

Timothy McHugh

International Journal of Infectious Diseases, 2021

View PDFchevron_right

Tuberculosis and HIV: Renewed Challenge

Marcus Conde

Memórias do Instituto Oswaldo Cruz, 1998

View PDFchevron_right

New regimens for reducing the duration of treatment of drug-susceptible pulmonary tuberculosis

Marcus Conde

Drug Development Research, 2011

View PDFchevron_right

Do we need bacteriological confirmation of cure in uncomplicated tuberculosis?

Ibrahim Abubakar

European Respiratory Journal, 2013

View PDFchevron_right

Scaling up interventions to achieve global tuberculosis control: Progress and new developments

H Getahun

2012

View PDFchevron_right